Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
Funding for multicenter, international phase 2/3 clinical trials on medicinal products for rare cancer treatment (including drug repurposing).
Lloc de presentació
HMRIB and PSMAR staff who need more information should contact::
Research Grants and Contracts Office. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00.
Carol Barnwell: [email protected] Ext.: 1670
Marta López: [email protected] Ext.: 1576
Convocatòria (URL)
https://www.fondation-arc.org/attract
Informació addicional
The submission of proposals follows a two-stage procedure:
  • Submission deadline for pre-proposals: 11/10/2024
  • Submission deadline for full-proposals: 30/04/2025

  • Requisits
  • Main applicants as well as research consortium partners should be located in one of the funding countries (Belgium, France, the Netherlands, Spain), with a minimum of 2 participating countries.
  • Applicants (funding recipients) should be either Academic research groups or Clinical/Public health sector research groups.
  • To support swift enrolment of study patients in clinical trials, inclusion centers outside of the funding countries may be included in the proposal. Public-private collaborations are accepted under strict conditions; note that private parties will not receive direct funding.
  • Active patient participation in the set up and execution of the proposals is required. A strong regulatory and implementation strategy (incl. EMA advise, orphan designation, early HTA) is not obliged but highly recommended.

    Please see the guidelines to check the complete list of requirements.
  • Dotació
    FCAECC does not have a maximum funding per grant; the amount depends on the scientific and medical needs and should be justified in the requested budget. However, it is highly recommended to respect the available budget (€ 1M) and anticipated number of fundable research groups.
    Durada
    3 years

    Arxius

    Arxiu
    ATTRACT2025_CallText.pdf